Bain Capital Life Sciences Investors, LLC Dynavax Technologies Corp Transaction History

Bain Capital Life Sciences Investors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $14.8 Million - $19.8 Million	-1,500,000 Reduced 38.31%	2,415,000 $31.2 Million
Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $15.4 Million - $19.9 Million	-1,500,000 Reduced 27.7%	3,915,000 $41.7 Million
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $29.8 Million - $52.3 Million	-3,000,000 Reduced 35.65%	5,415,000 $56.5 Million
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $30.7 Million - $66.6 Million	-3,356,708 Reduced 28.52%	8,415,000 $162 Million
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $6.35 Million - $9.63 Million	875,935 Added 8.04%	11,771,708 $116 Million
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $49.8 Million - $122 Million	10,895,773 New	10,895,773 $107 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $40.6 Million - $61 Million	-10,895,773 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $6.37 Million - $19.7 Million	2,165,066 Added 24.8%	10,895,773 $96.6 Million
Q1 2020 May 15, 2020	BUY	$2.27 - $6.2 $632,131 - $1.73 Million	278,472 Added 3.29%	8,730,707 $30.8 Million
Q3 2019 Nov 14, 2019	BUY	$2.69 - $4.85 $22.7 Million - $41 Million	8,452,235 New	8,452,235 $30.3 Million

257

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.44B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.